Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  Pacific Biosciences of California    P09   US69404D1081

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Deutsche Boerse Ag
02/23/2015 02/24/2015 02/25/2015 02/26/2015 02/27/2015 Date
5.918(c) 6.043(c) 5.978(c) 5.98(c) 5.548(c) Last
0 0 0 0 0 Volume
+0.24% +2.11% -1.08% +0.03% -7.22% Change
More quotes
Company
Pacific Biosciences of California, Inc. develops, manufactures and markets an integrated platform for genetic analysis.It has developed a technology to study the synthesis and regulation of DNA combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry, and... 
Sector
Advanced Medical Equipment & Technology
Calendar
03/02 | 01:30pmPresentation
More about the company
Surperformance© ratings of Pacific Biosciences of Cal
Trading Rating : Investor Rating :
More Ratings
Chart PACIFIC BIOSCIENCES OF CAL
Duration : Period :
Pacific Biosciences of Cal Technical Analysis Chart | P09 | US69404D1081 | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 72,7 M
EBIT 2015 -65,2 M
Net income 2015 -68,1 M
Debt 2015 -
Yield 2015 -
Sales 2016 81,3 M
EBIT 2016 -67,9 M
Net income 2016 -69,9 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 6,40x
Capi. / Sales 2016 5,73x
Capitalization 466 M
More Financials
Latest news on PACIFIC BIOSCIENCES OF CAL
08:07a PACIFIC BIOSCIENCES OF CALIFORNIA : DNAnexus Enables Seamless Assembly of PacBio..
07:31a Pacific Biosciences Enables Reference-Quality De Novo Human Genome Assemblies
02/25 PACIFIC BIOSCIENCES OF CALIFORNIA : Patent Issued for Methods and Compositions f..
02/11 PACIFIC BIOSCIENCES OF CALIFORNIA : Reports Fourth Quarter 2014 Financial Result..
02/03 PACIFIC BIOSCIENCES OF CALIFORNIA : reports 4Q loss
02/03 PACIFIC BIOSCIENCES OF CALIFORNIA : Entry into a Material Definitive Agreement, ..
02/03 PACIFIC BIOSCIENCES OF CALIFORNIA : Results of Operations and Financial Conditio..
02/03 Pacific Biosciences Reports Fourth Quarter 2014 Financial Results
More news
Sector news Advanced Medical Equipment & Technology - NEC
10:08a Cardinal to buy J&J vascular technology unit Cordis for $1.9 billion
09:42a Wall St. inches up in wake of February rally
08:01a VARIAN MEDICAL SYSTEMS : Mount Elizabeth Novena Hospital to Deliver First TrueBe..
Plus d'actualités du secteur Advanced Medical Equipment & Technology - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF